Related references
Note: Only part of the references are listed.18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis
Myung-Hee Moon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Neuroprotective Effects of Dehydroglyasperin C through Activation of Heme Oxygenase-1 in Mouse Hippocampal Cells
Hyo Jung Kim et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
CB1 receptor antagonists: new discoveries leading to new perspectives
E. Kirilly et al.
Acta Physiologica (2011)
Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs
Pradeep J. Nathan et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
F. D. Christopoulou et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Metabolic profiling of roots of liquorice (Glycyrrhiza glabra) from different geographical areas by ESI/MS/MS and determination of major metabolites by LC-ESI/MS and LC-ESI/MS/MS
Paola Montoro et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Endocannabinoid signaling and energy metabolism: A target for dietary intervention
Jeffrey Kim et al.
NUTRITION (2011)
Energy balance regulation by endocannabinoids at central and peripheral levels
Carmelo Quarta et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier et al.
BIOCHEMICAL PHARMACOLOGY (2010)
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
Tony Jourdan et al.
DIABETES (2010)
Cell line models for differentiation: preadipocytes and adipocytes
Sylvia P. Poulos et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Hexane/ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin
Han Jin Cho et al.
FOOD CHEMISTRY (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The role of the endocannabinoid system in lipogenesis and fatty acid metabolism
Roberto Vettor et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Adipogenic and energy metabolism gene networks in longissimus lumborum during rapid post-weaning growth in Angus and Angus x Simmental cattle fed high-starch or low-starch diets
Daniel E. Graugnard et al.
BMC GENOMICS (2009)
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
K. Eckardt et al.
DIABETOLOGIA (2009)
Adipose tissue-skeletal muscle crosstalk: are endocannabinoids an unwanted caller?
M. J. Watt
DIABETOLOGIA (2009)
Selective inhibition of 11β-hydroxysteroid dehydrogenase 1 by 18α-glycyrrhetinic acid but not 18β-glycyrrhetinic acid
Dirk Classen-Houben et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation
Sevasti Karaliota et al.
OBESITY (2009)
The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids
Tara M. D'Eon et al.
DIABETES (2008)
Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese patients Pooled 1-year data from the Rimonabant in Obesity (RIO) program
Luc Van Gaal et al.
DIABETES CARE (2008)
Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats
Andreas W. Herling et al.
ENDOCRINOLOGY (2008)
Endocannabinoids and the Control of Energy Homeostasis
George Kunos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endocannabinoids, adipose tissue and lipid metabolism
C. Pagano et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cannabinoid type 1 receptor: Another arrow in the adipocytes' bow
L. Bellocchio et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Dysregulation of peripheral endocannabinoid levels in hyperglycernia and obesity: Effect of high fat diets
Isabel Matias et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Lipolysis and the integrated physiology of lipid energy metabolism
Shupei Wang et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake
V. Gasperi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (Linn) in rats
Nishant P. Visavadiya et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary-zone electrophoresis (CZE)
F Rauchensteiner et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Endocannabinoid control of food intake and energy balance
V Di Marzo et al.
NATURE NEUROSCIENCE (2005)
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile
B Poirier et al.
DIABETES OBESITY & METABOLISM (2005)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
In silico prediction of blood-brain barrier permeation
DE Clark
DRUG DISCOVERY TODAY (2003)
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
M Bensaid et al.
MOLECULAR PHARMACOLOGY (2003)
Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine
LA Baltina
CURRENT MEDICINAL CHEMISTRY (2003)
Share Paper
